29.03.2017
- UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...
03.03.2017
- Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...
19.12.2016
- Major US drugmaker Pfizer will use IBM Watson Health’s artificial intelligence technology to help in its efforts to find new cancer medicines. The deal will use the Watson for Drug...
10.10.2016
- As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...
04.10.2016
- Bayer and Evotec have signed a five-year multi-research pact to develop multiple clinical candidates to treat chronic kidney diseases. Both of the German companies will contribute...
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
19.07.2016
- Bayer and X-Chem Pharmaceuticals have expanded their global drug discovery collaboration, which was launched in 2012 and spans multiple therapeutic areas and target classes. The...
07.03.2016
- French pharmaceutical company Ipsen is paying up to $855 million for the rights to Exelixis’ cancer drug Cabozantinib. Under the deal, Exelixis gains exclusive commercialization...
